Registration for PeproTech.com is no longer available. To order your PeproTech products online, register or logon to ThermoFisher.com.

Resources & Support

References

First Author
Karlshøj, S
Title
Molecular Mechanism of Action for Allosteric Modulators and Agonists in CC-chemokine Receptor 5 (CCR5).
Citation
The Journal of Biological Chemistry; 2016 Dec 23; 291(52) pg26860-26874
PubMed ID
27834679
Show Usages
Product Cited
Cross-Reactivity
Applications
300-08
Hamster
in vitro
First Author
Maeda, K
Title
Structural and molecular interactions of CCR5 inhibitors with CCR5.
Citation
The Journal of Biological Chemistry; 2006 May 5; 281(18) pg12688-98
PubMed ID
16476734
Show Usages
Product Cited
Cross-Reactivity
Applications
First Author
Alvarez Arias, D
Title
Constitutive activation of CCR5 and CCR2 induced by conformational changes in the conserved TXP motif in transmembrane helix 2.
Citation
The Journal of Biological Chemistry; 2003 Sep 19; 278(38) pg36513-21
PubMed ID
12837756
Show Usages
Product Cited
Cross-Reactivity
Applications
300-04
Hamster
in vitro
300-08
Hamster
in vitro
300-09
Hamster
in vitro
300-15
Hamster
in vitro
First Author
Mueller, A
Title
Pathways for internalization and recycling of the chemokine receptor CCR5.
Citation
Blood; 2002 Feb 1; 99(3) pg785-91
PubMed ID
11806977
Show Usages
Product Cited
Cross-Reactivity
Applications
First Author
Miyakawa, T
Title
Identification of amino acid residues critical for LD78beta, a variant of human macrophage inflammatory protein-1alpha, binding to CCR5 and inhibition of R5 human immunodeficiency virus type 1 replication.
Citation
The Journal of Biological Chemistry; 2002 Feb 15; 277(7) pg4649-55
PubMed ID
11734558
Show Usages
Product Cited
Cross-Reactivity
Applications
First Author
Maeda, K
Title
Novel low molecular weight spirodiketopiperazine derivatives potently inhibit R5 HIV-1 infection through their antagonistic effects on CCR5.
Citation
The Journal of Biological Chemistry; 2001 Sep 14; 276(37) pg35194-200
PubMed ID
11454872
Show Usages
Product Cited
Cross-Reactivity
Applications
First Author
Nibbs, R J
Title
LD78beta, a non-allelic variant of human MIP-1alpha (LD78alpha), has enhanced receptor interactions and potent HIV suppressive activity.
Citation
The Journal of Biological Chemistry; 1999 Jun 18; 274(25) pg17478-83
PubMed ID
10364178
Show Usages
Product Cited
Cross-Reactivity
Applications
showing 7 of 7